← Back to Search

Geriatric Care Model for Dialysis

N/A

Waitlist Available

Led By Rasheeda K Hall, MD, MBA, MHS, FASN

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Community-dwelling dialysis patients 55 and older

Be older than 18 years old

Must not have

Advanced dementia

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 4, 8, 12 months

Summary

This trial aims to improve dialysis care by getting input from key stakeholders and conducting a small test study to gather important evidence for a larger study in the future. Summary: "This trial aims to

Who is the study for?

This trial is for community-dwelling dialysis patients aged 55 and older, who may have some cognitive impairment. Those with severe cognitive issues can join if they have a caregiver present to assist them during the study.

What is being tested?

The study is testing a new Geriatric Care Model against the usual care given to older adults on dialysis. It's set up as a pilot randomized controlled trial, meaning participants are randomly assigned to one of the two approaches.

What are the potential side effects?

Since this trial compares different care models rather than medications, side effects aren't typical in the same way as drug trials. However, changes in care could lead to variations in comfort or well-being.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 55 or older and receive dialysis while living at home.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have advanced dementia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4, 8, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4, 8, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4, 8, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in geriatric problem management as measured by survey

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Geriatric Care ModelActive Control1 Intervention

While specifics of the intervention will be finalized after aim 2, the investigators anticipate participants will complete the GOLD and telehealth prioritization visit. Information gathered will guide the research geriatric team's recommendation report to the participants' dialysis care team. The dialysis teams will receive training on how to use the recommendation report and local resources to initiate geriatric problem management.

Group II: Usual CarePlacebo Group2 Interventions

Participants will receive usual dialysis care for 12 months, then they will receive the geriatric care model.

0 / 2Eligibility criteria met